PPD (NASDAQ:PPD)’s share price traded down 5.1% on Tuesday . The company traded as low as $28.19 and last traded at $28.44, 776,290 shares were traded during mid-day trading. A decline of 59% from the average session volume of 1,906,649 shares. The stock had previously closed at $29.98.
In other news, COO William J. Sharbaugh bought 30,000 shares of the stock in a transaction dated Monday, February 10th. The stock was bought at an average price of $32.25 per share, for a total transaction of $967,500.00. Also, CEO David S. Simmons acquired 40,000 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The shares were bought at an average price of $32.25 per share, with a total value of $1,290,000.00. In the last quarter, insiders bought 77,400 shares of company stock valued at $2,496,150.
About PPD (NASDAQ:PPD)
PPD, Inc provides drug development services to the biopharmaceutical industry worldwide. The company offers clinical development and laboratory services to the pharmaceutical, biotechnology, and medical device and government organizations, as well as other industry participants. It operates in two segments, Clinical Development Services and Laboratory Services.
Read More: Risk Tolerance
Receive News & Ratings for PPD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PPD and related companies with MarketBeat.com's FREE daily email newsletter.